Study Title: A Phase I/Randomized Phase II, Open-Label Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of mFOLFIRINOX With or Without BNT321 as Adjuvant Therapy Following Curative Resection in Patients with Pancreatic Adenocarcinoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Albert Lockhart, at lockhara@musc.edu.Study Coordinator, Bria Sanders, at sandebri@musc.edu.Trial opened at the following institutions: Medical University of South Carolina